Design and Evaluation of Hydrogel-Thickened Microemulsion for Topical Delivery of Minoxidil Minoxidil Microemulsions for Topical Delivery
Iranian Journal of Pharmaceutical Sciences,
卷 9 编号 4 (2013),
1 octubre 2013
,
第 1-14 页
https://doi.org/10.22037/ijps.v9.40854
摘要
The available minoxidil formulations for topical application suffer with major drawback having less contact time with the scalp which requires repeated application. Hence, the present study was aimed to investigate the effect of microemulsions and microemulsion based hydrogel systems (MEHs) for increased percutaneous penetration of minoxidil. Minoxidil microemulsions were developed by following conventional titration method using oleic acid as oil phase, Tween 80 as surfactant and polyethyleneglycol 200 as co-surfactant. Smix is a surfactant and co-surfactant mixture, whose ratios in the mixture were optimized using the pseudo ternary phase diagram. The physicochemical interaction between the drug and polymer were investigated by FTIR. Prepared microemulsions and MEHs were evaluated for drug content, viscosity, pH, in vitro, ex vivo permeation, skin irritation and stability studies. The drug content and viscosity in prepared microemulsions was found ranged from 56.77±2.88 to 92.85±1.59 %, and 89.12±1.801 to 144.24±0.95 cps respectively. The Ex vitro skin permeation from these microemulsions was sustained over 24 h with drug release around 32±3.26 to 99±3.78 % with more retardation in formulation F4 (oleic acid:Smix:water 58%:40%:2%). F4 was incorporated into hydroxypropyl cellulose gel to get MEH formulation and both were compared with the marketed topical solution. Marketed preparation was diffused at faster rate in comparison to the microemulsion and MEH. The drug release order was found to be Higuchi’s with non-Fickian “anomalous” mechanism at controlled rate. The flux of the microemulsion F4 and MEH was found around 70.11±10.81 and 90.26±11.46 (μg/cm2/hr) with permeation coefficient around 27.18±6.69 and 30.21±5.16 (cm/hr). The microemulsion did not show any dermatological reactions when tested. The microemulsion was found stable on storage and results suggested that microemulsions and MEHs could be more promising for topical delivery of minoxidil in hair loss treatment in comparison to solution based formulations.
- Hydrogel
- minoxidil
- microemulsion
- oleic acid
- polyethyleneglycol 200
- Tween 80
##submission.howToCite##
参考
[2] Price VH. Treatment of hair loss. N Engl J Med (1999) 341(13):964-973.
[3] Meisheri KD, Cipkus LA, Taylor CJ. Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther (1988) 245(3):751-760.
[4] Barry BW. Novel mechanisms and device to enable successful transdermal drug delivery. Eur J Pharm Sci (2001) 14 (2):101-114.
[5] Moser K, Kriwet K, Naik A, Kalia NK, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm (2001) 52 (2):103-112.
[6] Osborne DW, Ward AJI, Neil KJO. Microemulsions as topical drug delivery vehicles: In vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol (1991) 43 (6):451-454.
[7] Trotta M, Pattarino F, Gasco MR. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Helvetiea (1996) 71(2):135-140.
[8] Badawi AA, Nour SA, Sakran WS, El-Mancy SMS. Preparation and evaluation of microemulsion systems containing salicylic acid. AAPS PharmSciTech (2009) 10(4): 1081-1084.
[9] Nazar MF, Khan AM, Shan SS. Microemulsion system with improved loading of piroxicam: a study of microstructure. AAPS PharmSciTech (2009) 10(4): 1286-1294.
[10] Malakar J, Sen SO, Nayak AK Sen KK. Development and evaluation of microemulsions for transdermal delivery of insulin. ISRN Pharmaceutics (2011) Article ID 789150: 1-7.
[11] Yang JH, Kim YI, Kim KM. Preparation and evaluation of aceclofenac microemulsions for transdermal delivery systems. Archives Pharm Res (2002) 24(4): 534-540.
[12] Delgado-Charro MB, Iglesias-Vilas G, Blanco-Mendez J, Lopez-Quintela MA, Marty JP, Guy RH. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur J Pharm Biopharm (1997) 43(1): 37-42.
[13] Peira E, Scolari P, Gasco MR. Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharm (2001)226(1-2): 47–51.
[14] Kreilgaard. Influence of microemulsions of cutaneous drug delivery. Adv Drug Del Rev (2002) 54(1): 77-98.
[15] Patel MR, Patel RB, Parikh JB, Solanki AB, Patel BG. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech (2009) 10(3): 917-923.
[16] Baboota S, Al-Azaki A, Kohli K, Ali J, Dixit N, Shakeel F. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. PDA J Pharm Sci Technol (2007) 61(4): 276-85.
[17] Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. Microemulsions for topical delivery of estradiol. Int J Pharm (2003) 254(2): 99-107.
[18] Chen HB, Chang XL, Weng T. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release (2004) 98(3): 427–436.
[19] Sintov AC, Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J Control Release (2004) 95(2): 73-183.
[20] Chena H, Moub D, Dub D, Changa X, Zhua JLD, Xub H, Yang X. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration. Int J Pharmaceutics (2007) 341(1-2): 78–84.
[21] Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm (2006) 327(1-2): 58–64.
[22] Berner B, John VA. Pharmacokinetic characterization of transdermal delivery systems. Clin Pharmacokinet (1994) 26(2): 121–134
[23] Hilton J, Woollen BH, Scott RC, Auton TR, Trbilcock KL, Wilks MF. Vehicles effect on in vitro percutaneous absorption through rat and human skin. Pharm Res (1994) 11(10): 1396-1400.
[24] Derle DV, Sagar BSH, Pimpale R. Microemulsion as a vehicle for transdermal permeation of nimesulide. Indian J Pharm Sci (2006) 68(5): 622-625.
[25] British Pharmacopoeia, 6th edition Volume IV, Published by the Stationery office on behalf of the Medicines and Health care products Regulatory agency (MHRA), 2009. Page: S88.
- 摘要 ##plugins.themes.ojsPlusA.frontend.article.viewed##: 139 ##plugins.themes.ojsPlusA.frontend.article.times##
- IJPS_Volume 9_Issue 4_Pages 1-14 (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 54 ##plugins.themes.ojsPlusA.frontend.article.times##